Pioglitazone + metformin: new drug. A combination product to avoid.
More serious adverse effects, and still no tangible proof of efficacy.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017277:Drug Approval; D004338:Drug Combinations; D005060:Europe; D006801:Humans; D008687:Metformin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D004338:Drug Combinations; D045162:Thiazolidinediones; D008687:Metformin